(Q45105442)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482637%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Pluronic block copolymers and Pluronic poly(acrylic acid) microgels in oral delivery of megestrol acetate (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482637%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

0 references

Valery Alakhov

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482637%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Grzegorz Pietrzynski

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482637%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Kishore Patel

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482637%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Lev Bromberg

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482637%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 October 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482637%20AND%20SRC:MED&resulttype=core&format=json

Journal of Pharmacy and Pharmacology

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482637%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482637%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482637%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

1233-1241

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482637%20AND%20SRC:MED&resulttype=core&format=json

Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

Sensitization of cells overexpressing multidrug-resistant proteins by pluronic P85.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

Megestrol acetate reverses multidrug resistance and interacts with P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

An essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

Improvement of oral drug treatment by temporary inhibition of drug transporters and/or cytochrome P450 in the gastrointestinal tract and liver: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

Weekly oral paclitaxel as first-line treatment in patients with advanced gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

Clinical trials of modulation of multidrug resistance. Pharmacokinetic and pharmacodynamic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

Emerging Trends in Oral Delivery of Peptide and Protein Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

Nanosizing: a formulation approach for poorly-water-soluble compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

Sensitization to doxorubicin resistance in breast cancer cell lines by tamoxifen and megestrol acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

Synthesis of radiolabeled congeners of the carbomers: (14)C-labeled poly(acrylic acid)s

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

Solid Dispersions: Revival with Greater Possibilities and Applications in Oral Drug Delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

Peroral route: an opportunity for protein and peptide drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

Augmentation of vincristine cytotoxicity by megestrol acetate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

Bioadhesive microspheres as a controlled drug delivery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

Formulation aspects in the development of osmotically controlled oral drug delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

Megestrol acetate for treatment of cachexia associated with human immunodeficiency virus (HIV) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

Reversal of the human and murine multidrug-resistance phenotype with megestrol acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357044427

21 January 2018

Identifiers

DOI

10.1211/0022357044427

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15482637%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference